Patents by Inventor Tillmann TAUBE

Tillmann TAUBE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATMENT OF SOLID MALIGNANCIES INCLUDING ADVANCED OR METASTATIC SOLID MALIGNANCIES
    Publication number: 20190290652
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof for treating patients suffering from solid malignancies including advanced or metastatic solid malignancies comprising a high frequency administration of Volasertib according to a specific dosage schedule.
    Type: Application
    Filed: June 13, 2019
    Publication date: September 26, 2019
    Inventors: Tillmann TAUBE, Gerd Michael MUNZERT, Dorothea RUDOLPH
  • COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME I
    Publication number: 20190240241
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Decitabine or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Application
    Filed: April 16, 2019
    Publication date: August 8, 2019
    Inventors: Dorothea RUDOLPH, Tillmann TAUBE
  • COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME II
    Publication number: 20190240242
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Azacitidine or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Application
    Filed: April 16, 2019
    Publication date: August 8, 2019
    Inventors: Dorothea RUDOLPH, Maria del Roser CALVO VERGES, Tillmann TAUBE
  • Treatment of myelodysplastic syndrome
    Patent number: 9956225
    Abstract: The present invention relates to the use of Volasertib or a pharmaceutically acceptable salt thereof or the hydrate thereof for treating myelodysplastic syndrome (MDS).
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: May 1, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Dorothea Rudolph, Tillmann Taube
  • Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
    Patent number: 9867831
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Quizartinib or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: January 16, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Tillmann Taube, Dorothea Rudolph
  • COMBINATION THERAPY WITH VOLASERTIB
    Publication number: 20170173023
    Abstract: Disclosed is the use of Volasertib or a salt or a hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) comprising administering a high dose of Volasertib in combination with fludarabine, cytarabine and Granulocyte colony-stimulating factor (GCSF) or in combination with fludarabine, cytarabine, GCSF and a daunorubicin citrate liposome injection.
    Type: Application
    Filed: March 3, 2017
    Publication date: June 22, 2017
    Inventor: Tillmann TAUBE
  • TREATMENT OF MYELODYSPLASTIC SYNDROME
    Publication number: 20170157130
    Abstract: The present invention relates to the use of Volasertib or a pharmaceutically acceptable salt thereof or the hydrate thereof for treating myelodysplastic syndrome (MDS).
    Type: Application
    Filed: February 24, 2017
    Publication date: June 8, 2017
    Inventors: Dorothea RUDOLPH, Tillmann TAUBE
  • COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME I
    Publication number: 20170157159
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Decitabine or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Application
    Filed: February 24, 2017
    Publication date: June 8, 2017
    Inventors: Dorothea RUDOLPH, Tillmann TAUBE
  • COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME II
    Publication number: 20170157158
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Azacitidine or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Application
    Filed: February 24, 2017
    Publication date: June 8, 2017
    Inventors: Dorothea RUDOLPH, Maria del Roser CALVO VERGES, Tillmann TAUBE
  • METHOD FOR TREATMENT OF SOLID MALIGNANCIES INCLUDING ADVANCED OR METASTATIC SOLID MALIGNANCIES
    Publication number: 20160303131
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof for treating patients suffering from solid malignancies including advanced or metastatic solid malignancies comprising a high frequency administration of Volasertib according to a specific dosage schedule.
    Type: Application
    Filed: June 22, 2016
    Publication date: October 20, 2016
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Tillmann TAUBE, Gerd Michael MUNZERT, Dorothea RUDOLPH
  • METHOD FOR TREATING ACUTE MYELOID LEUKEMIA
    Publication number: 20160243124
    Abstract: The present invention relates to the use of BI 6727 or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) comprising the administration of a high dose of BI 6727 according to a specific dosage schedule, optionally in combination with cytarabine.
    Type: Application
    Filed: May 5, 2016
    Publication date: August 25, 2016
    Inventors: Tillmann TAUBE, Gerd Michael MUNZERT, Dorothea Ingrid RUDOLPH
  • Method for treatment of advanced solid tumors
    Patent number: 9370535
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or a hydrate thereof in combination with Cisplatin or Carboplatin or a salt thereof or a hydrate thereof for treating patients suffering from advanced and/or metastatic solid tumors.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: June 21, 2016
    Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Tillmann Taube, Gerd Michael Munzert, Dorothea Rudolph
  • Method for treating acute myeloid leukemia
    Patent number: 9358233
    Abstract: The present invention relates to the use of BI 6727 or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) comprising the administration of a high dose of BI 6727 according to a specific dosage schedule, optionally in combination with cytarabine.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: June 7, 2016
    Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Tillmann Taube, Gerd Munzert, Dorothea Rudolph
  • COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA and MYELODYSPLASTIC SYNDROME
    Publication number: 20160095863
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Quizartinib or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Application
    Filed: September 21, 2015
    Publication date: April 7, 2016
    Inventors: Tillmann TAUBE, Dorothea RUDOLPH
  • TREATMENT OF MYELODYSPLASTIC SYNDROME
    Publication number: 20150031699
    Abstract: The present invention relates to the use of Volasertib or a pharmaceutically acceptable salt thereof or the hydrate thereof for treating myelodysplastic syndrome (MDS).
    Type: Application
    Filed: July 24, 2014
    Publication date: January 29, 2015
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Dorothea RUDOLPH, Tillmann TAUBE
  • COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME II
    Publication number: 20150031643
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Azacitidine or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Application
    Filed: July 24, 2014
    Publication date: January 29, 2015
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Dorothea RUDOLPH, Maria del Roser CALVO VERGES, Tillmann TAUBE
  • COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME I
    Publication number: 20150031642
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Decitabine or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Type: Application
    Filed: July 24, 2014
    Publication date: January 29, 2015
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Dorothea RUDOLPH, Tillmann TAUBE
  • COMBINATION THERAPY WITH VOLASERTIB
    Publication number: 20140154304
    Abstract: Disclosed is the use of Volasertib or a salt or a hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) comprising administering a high dose of Volasertib in combination with fludarabine, cytarabine and Granulocyte colony-stimulating factor (GCSF) or in combination with fludarabine, cytarabine, GCSF and a daunorubicin citrate liposome injection.
    Type: Application
    Filed: November 25, 2013
    Publication date: June 5, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventor: Tillmann TAUBE
  • METHOD FOR TREATMENT OF SOLID MALIGNANCIES INCLUDING ADVANCED OR METASTATIC SOLID MALIGNANCIES
    Publication number: 20130131069
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof for treating patients suffering from solid malignancies including advanced or metastatic solid malignancies comprising a high frequency administration of Volasertib according to a specific dosage schedule.
    Type: Application
    Filed: May 9, 2012
    Publication date: May 23, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Tillmann TAUBE, Gerd Michael MUNZERT, Dorothea RUDOLPH
  • METHOD FOR TREATMENT OF ADVANCED SOLID TUMORS
    Publication number: 20130122111
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or a hydrate thereof in combination with Cisplatin or Carboplatin or a salt thereof or a hydrate thereof for treating patients suffering from advanced and/or metastatic solid tumours.
    Type: Application
    Filed: May 9, 2012
    Publication date: May 16, 2013
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Tillmann TAUBE, Gerd Michael MUNZERT, Dorothea RUDOLPH